Dr. Hina Khan is a Thoracic Oncologist at the Brown University Health Cancer Institute in Providence, Rhode Island. She is the Director of the Multidisciplinary Lung Nodule Management Program and Site Director of the Thoracic Oncology Multidisciplinary Clinic at the Brown University Health Cancer Institute at Miriam Hospital. Dr. Khan has led several University, pharmaceutical and NIH-funded projects as a principal investigator. Her translational research focuses on way to enhance responses to immune checkpoint inhibitors and exploring novel biomarker of response to immunotherapy treatments in lung cancer. She is the site investigator for the CCC-19 (the COVID-19 and Cancer Consortium) and TERAVOLT (Thoracic cancers international COVID-19 collaboration) registries, studying outcomes of COVID-19 in lung cancer patients. Driven by a commitment to diversity, equity, and inclusion, she is actively engaged in community outreach and education. In support of her work on equitable lung cancer screening access, she was the recepient of the 2022 Robert A. Winn Career Development award (Winn CDA) funding her research on Lung Cancer Screening in the Underserved Populations of Rhode Island, demonstrating a significant benefit of navigators in increasing lung cancer screening rates. She serves on the SWOG Cancer Research Network, DEI Leadership Council focusessing on addressing inequities and disparities across trials at SWOG. She has studied the burden of Radon exposure on the Rhode Island community and its genomic imprints of Radon induced lung cancer.
